• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Gene Expression Pattern following Hypericin-PDT

Gene Expression Pattern following Hypericin-PDT

Barbara Krammer (ORCID: )
  • Grant DOI 10.55776/P17058
  • Funding program Principal Investigator Projects
  • Status ended
  • Start April 1, 2004
  • End February 28, 2007
  • Funding amount € 122,285
  • Project website

Disciplines

Medical-Theoretical Sciences, Pharmacy (100%)

Keywords

    Photodynamic, Human Cell Line, Hypericin, Tumor, Gene Expression, DNA array

Abstract Final report

Photodynamic Tumor Therapy (PDT) is a most promising novel approach to tumor treatment. It is based on the preferential uptake and retention of a photosensitizer by tumors and the production of reactive oxygen species (ROS) during irradiation of the accumulated photosensitizer in the tumor area with visible light. PDT is characterized by both, high tumor specificity and low side effects in contrast to radiation- or chemotherapy. The extract hypericin from Hypericum perforatum plants, commonly known as St. Johns wort, was introduced quite recently as a very powerful photosensitizer; it is successfully being applied in tumor diagnosis and tested for clinical treatment. Up to now, it has not been shown, whether low doses of hypericin may induce apoptosis in tumors to such a great extent as was found in vitro; yet the cell death mode will be crucial for any immunological anti-tumor-response following PDT. However, a deeper knowledge of the steps in the signaling pathways following PDT is still lacking. The understanding of where these intracellular signals originate and how they are integrated and interpreted by the cell will lead to more insight into the proteins that are involved in regulating and executing the cell death program(s) and in modulating immunological anti-tumor mechanisms. The aim of the present project is therefore to uncover the basic processes leading to successful hypericin-PDT by a large scale gene expression analysis following treatment of the squamous cell carcinoma cell line A-431, which will be used as a human tumor cell model. Differentially expressed genes shall be identified on high density cDNA arrays with approximately 10 000 ESTs and a selected set shall be verified by real-time PCR. Knowledge of the expression pattern of cancer cells following PDT with hypericin may lead to novel approaches for enhancing the PDT effects of this promising photosensitizer. In addition, gene expression patterns of hypericin- and ALA-treated A-431 cells (from the preceding project) shall be compared. The differences of progression from photodynamic damage to apoptotic and/or necrotic cell death shall be analyzed and discussed.

Photodynamic tumour therapy (PDT) is a relatively new modality for the treatment of tumorous and non- tumourous lesions as well as for antibacterial and antiviral purposes. It is based on the preferential uptake and retention of a photosensitizer by target cells and the production of reactive oxygen species (ROS) during irradiation of the accumulated photosensitizer in the target cells with visible light of the appropriate wavelength leading the destruction of target cells via apoptosis and/or necrosis. Hypericin, which is extracted from St. John`s wort (Hypericum perforatum) is gaining rapidly in importance as photosensitizer for therapeutical use, since it is very effective in low doses, as well as fluorescence marker for diagnosis due to its bright fluorescence and high selectivity. The aim of the present project was to enlighten the basic molecular biological response of the model system A-431 cells to photodynamic treatment with hypericin (HYP-PDT) in a detailed and comprehensive manner. To meet this directive, gene expression patterns of HYP-PDT treated samples, which were taken at 1.5, 3, 5 and 8 hours post irradiation, as well as appropriate controls were studied using high-density cDNA arrays containing 9738 EST sequences. Verification of array results of selected genes was achieved by real-time PCR analysis on Biorad iCycler system. Clustering of gene expression changes detected on arrays, which were higher than twofold, to functional classes revealed (number of genes upregulated / number of genes downregulated): apoptosis (55/2), oxidative stress (25/4), cytoskeleton and cell attachment (24/12), proliferation and cell cycle (17/9), MAPK signalling pathway (17/5), protein transport (10/2), energy metabolism (8/7), G-protein pathways (6/2), RNA processing (6/2). Real-time PCR verification confirmed 25 genes as upregulated and 8 as downregulated out of 46 selected genes. Strongest downregulation (5.8 fold) showed thrombospondin 1 which is involved in angiogenesis, cell attachment and apoptosis. All other confirmed downregulated genes confirmed only weak expression changes (2-3fold) and are also related to cell attachment. Highest upregulation (>100fold) showed the early stress response genes CL-100, c-Fos, c-Jun and Not. All other confirmed upregulated genes showed only minor changes (most of them <10fold). This comprehensive study of changes in gene expression following HYP-PDT reveals the nature of cellular response to photodynamic treatment of A431 cells with hypericin involving several different molecular pathways (oxidative stress, MAPK, endoplasmatic reticulum stress response) as well as cell attachment, which is in contrast to the results of our previous FWF-funded project dealing with gene expression changes following ALA-PDT (P15143), where, due to the different localization of the sensitizer, mainly necrotic cell death and only very few changes in gene expression patterns were observed.

Research institution(s)
  • Universität Salzburg - 100%

Research Output

  • 1 Citations
  • 1 Publications

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF